Polyhydroxy Patents (Class 514/738)
-
Publication number: 20130324619Abstract: The disclosure relates to uses, methods and compositions for the inactivation of pathogens in biological compositions, using a glycol as a pathogen inactivating agent.Type: ApplicationFiled: December 23, 2011Publication date: December 5, 2013Applicant: Laboratoire Francais du Fractionnement et des BiotechnologiesInventor: Sami Chtourou
-
Publication number: 20130324618Abstract: The present invention concerns a method of enhancing milk production by a ruminant that includes providing a feed that contains sorbitol and at least one additional feed component, and orally feeding the feed to the ruminant, the ruminant ingesting about 100 grams, or less, of sorbitol per day.Type: ApplicationFiled: April 15, 2013Publication date: December 5, 2013Applicant: Land O'Lakes, IncInventor: Cindie M. Luhman
-
Publication number: 20130324504Abstract: The present invention is directed to pharmaceutical compositions comprising antispasmodic C4-C8aliphatic-1,2-diols and C4-C8aliphatic-1,2,3-triols and their use to relieve the spasms associated with pain. These agents may be administered topically or orally and may be combined with anti-inflammatory agents such as a non-steroidal anti-inflammatory drug or a corticosteroid. Administration of the C4-C8aliphatic-1,2-diols and C4-C8aliphatic-1,2,3-triols with vitamin D3 is indicated for conditions such as bone loss, weight gain and autoimmune diseases such as lupus and rheumatoid arthritis.Type: ApplicationFiled: March 13, 2013Publication date: December 5, 2013Inventor: Priti Sanghvi Shah
-
Patent number: 8591937Abstract: A method of feeding a ruminant that entails providing a feed that comprises sugar alcohol and at least one additional feed component, where the feed is free of rumen-protected fatty acid or comprises less than 10 weight percent rumen-protected fatty acid, based on the total weight of the feed and further entails orally supplying the feed to the ruminant during a pre-partum period when the ruminant is pregnant, where the ruminant ingests the feed and sugar alcohol during the pre-partum period.Type: GrantFiled: January 31, 2012Date of Patent: November 26, 2013Assignee: Purina Animal Nutrition LLCInventors: Paul A. Porter, Cindie M. Luhman
-
Publication number: 20130302385Abstract: The invention relates to a composition, especially a cosmetic composition, containing (a) a water-based gel phase; and (b) a water-in-oil emulsion phase.Type: ApplicationFiled: May 8, 2012Publication date: November 14, 2013Applicant: L'Oreal S.A.Inventors: Sara MUENZ, Gisela Perruna, Ashini Amin
-
Patent number: 8574609Abstract: Broad spectrum disinfecting and microbicidal compositions of biodegradable and environmentally friendly compositions containing esters formed from fatty organic alcohols and fatty carboxylic acids. These compositions display activities against the most resistant microbial forms including bacterial spores. The preparations can be used in health care, food processing, personal care and other industries where the use of harsh oxidizing chemicals is undesirable.Type: GrantFiled: May 2, 2011Date of Patent: November 5, 2013Inventor: John Alex Lopes
-
Publication number: 20130289131Abstract: The present invention relates to an injectable pharmaceutical formulation for the alleviation or reduction of joint irritation or for the reduction of worsening of existing joint inflammation, formulated for intra-articular injection comprising an active polyol ingredient, which polyol active ingredient is xylitol. Use of the intra-articular injectable formulations for the treatment of joint diseases or conditions including arthritis is described.Type: ApplicationFiled: June 22, 2011Publication date: October 31, 2013Inventor: David Segal
-
Publication number: 20130287817Abstract: A flowable biomedical implant for application to a bone defect to promote bone growth is provided. The flowable biomedical implant comprises a carrier matrix including a biodegradable polysaccharide and ceramic material. An impermeable membrane can be integrally formed at the surface of the carrier matrix by applying a crosslinking agent to the biodegradable polysaccharide mixed with ceramic materials.Type: ApplicationFiled: April 27, 2012Publication date: October 31, 2013Applicant: Warsaw Orthopedic, Inc.Inventors: Susan J. Drapeau, Daniel A. Shimko
-
Patent number: 8551458Abstract: The invention relates to a composition in the form of an oil-in-water emulsion containing an ester of fatty acid and of polyethylene glycol, an additional surfactant chosen from esters of C16-C22 fatty acid and of sorbitan and esters of C16-C22 fatty acid and of glycerol, a polycondensate of ethylene oxide and of propylene oxide consisting of polyethylene glycol and polypropylene glycol blocks, and a hydroxylated diphenylmethane derivative. The composition has good stability, in particular after 24 hours at 55° C. Application in caring for and making up keratinous substances.Type: GrantFiled: August 12, 2010Date of Patent: October 8, 2013Assignee: L'OrealInventors: Aldo Monello, Melanie Achram
-
Publication number: 20130261133Abstract: The compounds of the invention exhibit antiprotozoal, antimicrobial, and anticancer properties that are useful for the treatment or prevention of infections or cancer in a patient (e.g., a human). For example, the compounds and methods described herein can be used for the treatment or prevention of protozoal infections such as leishmaniasis, malaria, and trypanosoma infections, bacterial infections such as S. aureus and C. albicans, and cancers such as breast, colon, lung, or prostate cancer. The invention further provides methods of synthesizing such compounds as well as kits useful for administering the compounds.Type: ApplicationFiled: March 14, 2013Publication date: October 3, 2013Applicant: The University of MontanaInventors: John Howard Hoody, David Brian Bolstad
-
Publication number: 20130261192Abstract: A medical absorbable hemostatic and wound healing promoting material for bone wounds and a preparation method thereof. The absorbable hemostatic material for bone wounds is formed of 40-95% of a base material and 5-60% of an adjuvant, based on weight percent, wherein the base material is an oligosaccharide, a polysaccharide, or a mixture of the oligosaccharide and the polysaccharide, and the adjuvant includes (1) one or more polyhydric alcohols, (2) one or more vegetable oils, and (3) one or more emulsifying agents. The method for preparing the absorbable hemostatic and wound healing promoting material for bone wounds comprises mixing a base material and an adjuvant at prescribed amounts by chemical blending or latex blending, cooling to form a solid lump, packaging, and sterilizing.Type: ApplicationFiled: May 30, 2013Publication date: October 3, 2013Inventors: Peng Yang, Fei Xing, Xiangrui Song, Nan Shen
-
Publication number: 20130251818Abstract: Personal lubricants containing royal jelly, a glow powder or xylitol are provided.Type: ApplicationFiled: March 22, 2013Publication date: September 26, 2013Applicant: Nature Labs USA LLCInventors: Louis J. Rivers, IV, Kevin Stranen
-
Publication number: 20130245053Abstract: The present disclosure relates to pesticidal compositions and to methods for controlling pests such as insects and other arthropods. More particularly, the disclosure relates to a pesticidal compositions containing mineral oil and one or more additional components which, when used in combination, act synergistically to control insect and pest populations.Type: ApplicationFiled: May 8, 2013Publication date: September 19, 2013Inventor: Steven R. Sims
-
Patent number: 8535689Abstract: A bacterial autoinducer, CAI-1, was purified and its structure identified. Methods for synthesis of the autoinducer and its analogues were elucidated. Methods of using the autoinducer or its analogues for treating bacterial pathogenicity and bio film formation are described. Methods for prevention and treatment of cholera are described. Synthetic (S)-3-hydroxytridecan-4-one functions as well as natural CAI-1 in repressing production of the virulence factor toxin co-regulated pilus (TCP). Strategies are described to manipulate bacterial quorum sensing in the clinical arena.Type: GrantFiled: October 1, 2008Date of Patent: September 17, 2013Assignee: The Trustees of Princeton UniversityInventors: Bonnie Bassler, Martin Semmelhack, Douglas A. Higgins, Megan Eileen Bolitho, Kristina M. Kraml, Wai-Leung Ng
-
Patent number: 8529915Abstract: Short-chain 2- to 3-carbon alcohols are used as solvents for cooling agents in the preparation of topical therapeutic and cosmetic formulations. Some of these alcohols, especially ethanol, inhibit the ability of the cooling agent to activate its target receptor. In one embodiment of this invention, (R)-1,2-propanediol is used as an alcoholic solvent for the topical delivery of cooling agents to biological surfaces. This propanediol enantiomer has a minimum inhibitory effect on cooling with respect to standard 2- to 3-carbon alcoholic solvents, and functions to substantially protect the agent's cooling activity from inhibition when in the presence of a short-chain alcohol.Type: GrantFiled: March 16, 2011Date of Patent: September 10, 2013Inventor: Edward T. Wei
-
Patent number: 8529928Abstract: Biodegradable polymers incorporating biomolecules and methods of their use are provided. Certain aspects provide biomolecules crosslinked with diglycidyl esters. The disclosed compositions have numerous applications including cellular regeneration, wound healing, and cellular differentiation.Type: GrantFiled: July 6, 2007Date of Patent: September 10, 2013Assignee: Georgia Tech Research CorporationInventors: Yadong Wang, Blaine Zern, Christiane Gumera
-
Publication number: 20130225693Abstract: Disclosed is a topical skin care composition and corresponding methods for its use comprising water, a cationic surfactant, an occlusive skin conditioning agent, a humectant skin conditioning agent, and a silicone containing compound. The composition is dermatologically acceptable and is capable of moisturizing skin for at least twelve hours after topical application to skin even after multiple washings of the skin.Type: ApplicationFiled: May 24, 2011Publication date: August 29, 2013Applicant: MARY KAY INC.Inventor: Bob Walke
-
Patent number: 8519008Abstract: A method of improving the health of a first group of young monogastric mammals, the first group of young monogastric mammals nursing from a first lactating monogastric mammal during a pre-weaning period, the method including feeding the first lactating monogastric mammal an effective amount of an animal feed during the pre-weaning period, and feeding the first lactating monogastric mammal an effective amount of sugar alcohol during the pre-weaning period.Type: GrantFiled: January 22, 2003Date of Patent: August 27, 2013Assignee: Purina Animal Nutrition LLCInventors: Brenda de Rodas, Cindie M. Luhman, Bill L. Miller, Paul A. Porter
-
Patent number: 8519010Abstract: What is described herein are antimicrobial compositions which are defined blends of a 1,2-diol and phenoxyethanol which show broad activity against bacteria, fungi and mold spores. This activity is potentiated by the addition thereto of small amounts of a co-biocide for which the blend acts as a delivery system for the otherwise water-insoluble co-biocide.Type: GrantFiled: April 29, 2011Date of Patent: August 27, 2013Assignee: ISP Investments Inc.Inventors: John J. Merianos, Paul Garelick, Susan M. Lindstrom
-
Patent number: 8519009Abstract: Disclosed are compositions that include treated biodiesel glycerin. The disclosed compositions may be utilized as soil-amendments for controlling pests, weeds and for enhancing growth of plants. The biodiesel glycerin utilized in the disclosed compositions may be treated by one or more steps including neutralization, heating, refluxing, condensing, and distilling.Type: GrantFiled: February 29, 2008Date of Patent: August 27, 2013Assignee: Auburn UniversityInventors: Rodrigo Rodriguez-Kabana, Robert H. Walker
-
Patent number: 8513310Abstract: The invention relates to novel cosmetic uses of phytosphingosine or of one of its cosmetically acceptable salts, particularly its hydrochloride, as a slimming agent and/or as an active agent which stimulates the synthesis of leptin by adipocytes, for preparing a cosmetic composition intended for reducing subcutaneous excess fat. The invention also relates to a method of cosmetic treatment intended for obtaining a slimming effect on the human body according to which a cosmetic composition containing phytosphingosine or one of its cosmetically acceptable salts, particularly its hydrochloride, is applied on the parts of the body to be treated. The invention also relates to novel cosmetic compositions containing phytosphingosine or one of its cosmetically acceptable salts, particularly its hydrochloride, in combination with a lipolytic agent selected from the group consisting of CAMP and its derivatives, adenylate cyclase enzyme activating agents and phosphodiesterase enzyme inhibiting agents.Type: GrantFiled: May 4, 2010Date of Patent: August 20, 2013Assignee: LVMH RechercheInventors: Jocelyne Franchi, Françoise Pellicier
-
Patent number: 8512723Abstract: Antimicrobial compositions, especially those useful when applied topically, particularly to mucosal tissues (i.e., mucous membranes), including, in particular, an antimicrobial lipid component, such as a fatty acid ester, fatty ether, or alkoxide derivative thereof. The compositions can also include an enhancer component, a surfactant, a hydrophobic component, and/or a hydrophilic component. Such compositions provide effective topical antimicrobial activity and are accordingly useful in the treatment and/or prevention of conditions that are caused, or aggravated by, microorganisms (including viruses).Type: GrantFiled: September 8, 2004Date of Patent: August 20, 2013Assignee: 3M Innovative Properties CompanyInventors: Matthew T. Scholz, Dianne L. Gibbs, John T. Capecchi, Jeffrey F. Andrews
-
Patent number: 8513225Abstract: Disclosed herein is a composition containing a high concentration of PG is unexpectedly capable of quickly killing other bacteria, fungi, and/or virus in vitro that is indicative of its potential high efficacy in treating various skin infection. Embodiments disclosed herein relate to a composition and method for effective topical treatment of inflammatory skin lesions in mammals, comprising of a high concentration of propylene glycol alone, or in combination with an astringent. The PG at high concentrations can be regarded as an extremely effective, safe, topical, universal, microbicide.Type: GrantFiled: April 5, 2011Date of Patent: August 20, 2013Assignee: Winlind Skincare, LLCInventor: Win L Chiou
-
Publication number: 20130165530Abstract: A non-aqueous, non-aerosol foamable composition is provided that includes at least 40 wt % alcohol, based upon the total weight of the alcoholic composition; a foaming surfactant; and a skin benefit agent selected from the group consisting of emollients, humectants, occlusive agents, and other moisturizers to provide moisturization, skin softening, skin barrier maintenance, anti-irritation, or other skin health benefits. The foamable alcoholic composition forms a stable foam when mixed with air.Type: ApplicationFiled: December 20, 2012Publication date: June 27, 2013Applicant: GOJO INDUSTRIES, INC.Inventor: GOJO INDUSTRIES, INC.
-
Publication number: 20130150324Abstract: A salt-free emulsion for the treatment of dry eye and other ocular conditions is disclosed which contains castor oil and does not contain olive oil which prolongs TBUT and provides superior comfort.Type: ApplicationFiled: December 7, 2012Publication date: June 13, 2013Applicant: ALLERGAN, INC.Inventor: ALLERGAN, INC.
-
Patent number: 8445521Abstract: A synergistic antimicrobial composition. The composition contains at least two components. The first component is ortho-phenylphenol or its alkali metal or ammonium salts. The second component is 4,4-dimethyloxazolidine (DMOZ).Type: GrantFiled: September 15, 2010Date of Patent: May 21, 2013Assignee: Dow GLobal Technologies LLCInventor: Bei Yin
-
Publication number: 20130121969Abstract: The present invention relates to biocompatible, biodegradable polyurethane/urea polymeric compositions that are capable of in-vivo curing with low heat generation to form materials suitable for use in scaffolds in tissue engineering applications such as bone and cartilage repair. The polymers are desirably flowable and injectable and can support living biological components to aid in the healing process. They may be cured ex-vivo for invasive surgical repair methods, or alternatively utilized for relatively non-invasive surgical repair methods such as by arthroscope. The invention also relates to prepolymers useful in the preparation of the polymeric compositions, and to methods of treatment of damaged tissue using the polymers of the invention.Type: ApplicationFiled: October 31, 2012Publication date: May 16, 2013Applicant: POLYNOVO BIOMATERIALS PTY LIMITEDInventors: Raju Adhikari, Pathiraja Arachchillage Gunatillake
-
Publication number: 20130121937Abstract: Provided is a composition including, as an active ingredient, at least one selected from the group consisting of amines, amides and polyols. The cosmetic composition has an effect of preventing aging and may be applied in various industrial fields, including cosmetics.Type: ApplicationFiled: June 22, 2011Publication date: May 16, 2013Inventors: Hyeon Chung Kim, Hyun Hee Kim, Sung Il Park, Youn Joon Kim, Sang Hoon Han
-
Publication number: 20130123319Abstract: 3% Glycerin plus 3% amino acids intravenously used for nutritional purposes produces a rapid remission of an acute exacerbation in Behcet's Disease. External manifestations such as oral, vulva, penile and skin lesions rapidly heal when Glycerin is added to the amino acids. While the disease process in Behcet's Disease is likely improved by amino acids alone, the robustness of the healing of open lesions and the overall well-being of the patient in acute exacerbations is greatly enhanced by the addition of 3% Glycerin to the IV fluid. IV 3% Glycerin and 3% Amino Acids also produced remissions in Myasthenia Gravis, Guillain-Barre Disease, and Chronic Inflammatory Demyelinating Polyneuropathy. 3% Glycerin with amino acids could cause healing in many autoimmune diseases and can help external and internal lesions to heal. Glycerin also prevents bacteria from forming a biofilm which in most infections is necessary for the bacteria to become pathologic.Type: ApplicationFiled: November 15, 2011Publication date: May 16, 2013Inventor: Thomas Benedict Bryan
-
Patent number: 8440218Abstract: The present invention concerns a method of enhancing milk production by a ruminant that includes providing a feed that contains sorbitol and at least one additional feed component, and orally feeding the feed to the ruminant, the ruminant ingesting about 100 grams, or less, of sorbitol per day.Type: GrantFiled: October 21, 2005Date of Patent: May 14, 2013Assignee: Land O'Lakes, Inc.Inventor: Cindie M. Luhman
-
Patent number: 8440725Abstract: Disinfectant which has activity towards mycobacteria and has (a) 1-(2-ethylhexyl} glycerol ether and (b) one or more aromatic alcohols group including aryloxyalkanols, ethers and arylalkanols.Type: GrantFiled: July 1, 2010Date of Patent: May 14, 2013Assignee: Air Liquide Sante (International)Inventors: Wolfgang Beilfuss, Ralf Gradtke, Wolfgang Siegert, Michael Mohr, Klaus Weber
-
Patent number: 8436050Abstract: Antimicrobial compositions having synergistic combinations of octoxyglycerin and at least one other antimicrobial agent in formulations which are more effective than prior art compositions without causing increased irritation to the skin of the average user. In certain embodiments, skin irritation may be minimized by low concentrations of antimicrobials and/or the presence of soothing compounds such as zinc. Preferred embodiments include combinations of octoxyglycerin, a quaternary compound, and at least one other antimicrobial agent. Without being bound to any particular theory, it is hypothesized that the unexpected antimicrobial effectiveness of combinations of octoxyglycerin may result from an enhancement of the permeability of microbes to antimicrobials caused by octoxyglycerin. Hydroalcoholic gel composition containing alcohol, water, hydrogel, and emollient or emulsifier, wherein the composition has a viscosity of below 2000 centipoises at between 20 and 40° C.Type: GrantFiled: February 24, 2004Date of Patent: May 7, 2013Assignee: The Trustees of Columbia University in the City of New YorkInventors: Shanta Modak, Trupti A. Gaonkar, Lauser Caraos, Lester Sampath
-
Patent number: 8426475Abstract: The present invention provides effective and safe medicaments for the treatment of connective tissue diseases of the skin, particularly with respect to the treatment of cutaneous forms of Lupus Erythematous. The medicaments comprise as the therapeutically active ingredient a beta2 adrenoceptor agonist. The invention furthermore relates to dermatological compositions without skin sensitization properties and which contain enantiomerically pure or enriched R-enantiomers of a beta2 adrenoceptor agonist.Type: GrantFiled: April 12, 2006Date of Patent: April 23, 2013Assignee: Astion Development A/SInventors: Morten Sloth Weidner, Hans Christian Wulf
-
Patent number: 8404262Abstract: The present invention relates to improved compositions for controlling marine pest anemones, to methods of application of same, and to kits for the convenient dispensing of such compositions.Type: GrantFiled: December 31, 2008Date of Patent: March 26, 2013Assignee: Red Sea Fish Pharm Ltd.Inventor: Sharon Ram
-
Publication number: 20130058985Abstract: The present invention relates to a spray-pumpable composition for topical use on the skin comprising hydrophilic silicon dioxide, an emulsifier, at least one active ingredient and optionally one or more additives. The present invention further relates to a method for the preparation of a spray-pumpable composition for topical use on the skin and the use of hydrophilic silicon dioxide for the preparation of suspensions in emulsions, in particular oil-in-water emulsions.Type: ApplicationFiled: March 17, 2011Publication date: March 7, 2013Inventors: Maria Margaretha Martina Willems, Petrus Richardus Marinus Van De Lockand, Peter Meijlink Stiftstraat
-
Patent number: 8388949Abstract: The invention relates to the field of food compositions and their use. In particular compositions comprising at least 15 En % protein and pantothenic acid, or equivalents thereof, are provided, which are suitable for stimulating appetite.Type: GrantFiled: December 24, 2004Date of Patent: March 5, 2013Assignee: N.V. NutriciaInventor: Robert Johan Joseph Hageman
-
Patent number: 8388941Abstract: The use of a borate/polyol and zinc system to enhance the antimicrobial activity of multi-dose pharmaceutical compositions is described. The compositions do not require a conventional anti-microbial preservative and therefore are referred to as being ‘self-preserved’. The compositions possess sufficient antimicrobial activity to satisfy the preservative efficacy requirements of the USP for aqueous ophthalmic compositions.Type: GrantFiled: September 20, 2007Date of Patent: March 5, 2013Assignee: Alcon Research, Ltd.Inventors: Masood A. Chowhan, David J. Keith
-
Publication number: 20130029932Abstract: A composition for external use on skin that can be spread evenly on the skin, does not produce a liquid residue as a result of temperature change, and can suppress a feeling of sliminess of xanthan gum is provided. There are provided a composition for external use on skin containing 0.1% by mass to 10% by mass of a component (A) (a water-soluble polymer obtained by mixing agar with xanthan gum) and 30% by mass or more of a component (D) (water); the composition for external use on skin containing 0.5% by mass to 40% by mass of a divalent polyol as a component (B); the composition for external use on skin according to any one of the above compositions, which contains moisturizers as a component (C); and the composition for external use on skin according to any one of the above compositions, which contains oil as a component (E).Type: ApplicationFiled: March 14, 2011Publication date: January 31, 2013Applicant: This Nisshin Oillio Group, Ltd.sInventors: Hisanori Kachi, Makoto Matsuzawa, Minaho Ookubo, Keiichi Oyama, Aki Gotou, Masaaki Kojima, Takehiko Sakai, Junichi Itou
-
Patent number: 8361452Abstract: The invention provides a method for rapid bowel cleansing which includes the use of a mixture of polyethylene glycol and sodium phosphate(s). The method is particularly useful for preparing the bowel prior to surgery or diagnostic procedures such as colonoscopies. The invention further comprises methods for cleansing the bowel using these compositions, and bowel cleansing kits comprising these compositions.Type: GrantFiled: July 15, 2002Date of Patent: January 29, 2013Inventor: George M. Halow
-
Publication number: 20130005810Abstract: The present invention relates to a method for controlling the growth of bacterial biomass in an aqueous system, including adding to the aqueous system or contacting the aqueous system, with an efficient amount of an uncoupling agent selected from vanillin, pentaerythritol and a betaine of general formula (1): (R)3N+?[CH2]n?CO2? wherein the R groups, are identical or different, and are selected from a linear or branched alkyl group having 1 to 8 carbon atoms, and n is a number between 1 and 5.Type: ApplicationFiled: July 26, 2010Publication date: January 3, 2013Applicant: RHODIA OPERATIONSInventors: Roland Jacquot, Luc Louvel, Philippe Marchal, Philippe Marion, Gilles Moreau, Agnes Pilas-Begue
-
Publication number: 20130004444Abstract: The present invention relates to a composition including at least one C7 sugar, or derivative from esterification of said sugar, and a pharmaceutically acceptable carrier for treating alopecia. The present invention also relates to a method for cosmetically treating hair and nails, said method being intended to stimulate the growth thereof and/or slow the loss thereof. According to said method, a cosmetic composition including at least one C7 sugar, or derivative from esterification of said sugar, is administered. The present invention finally relates to a method for cosmetic care of hair and/or eyelashes and/or nails.Type: ApplicationFiled: December 15, 2010Publication date: January 3, 2013Inventors: Caroline Baudouin, Philippe Msika
-
Publication number: 20130004533Abstract: An agent comprising one or more components selected from among cowberry derivatives, mangosteen derivatives, scutellaria root derivatives, inositol and inositol phosphate, as an active ingredient, is a novel agent that can effectively promote production of platelet-derived growth factor-BB (PDGF-BB), which contributes to production of mesenchymal stem cells and stabilization of stem cells.Type: ApplicationFiled: July 1, 2011Publication date: January 3, 2013Inventors: Tsutomu Soma, Masato IIno, Haruyo Yamanishi
-
Publication number: 20120328537Abstract: A topical wound therapeutic treatment provides a gel preparation of very low toxicity and good antimicrobial properties. The gel can be formulated for both intra-oral and extra-oral use. The preparation uses high concentration Xylitol in combination with other agents including a non-Xylitol, sugarless, antimicrobial sweetener, such as DL-Menthol, oil of Peppermint, Sorbitol and Glycerin to achieve rapid wound healing with comfort. The dried gel forms a water soluble occlusive dressing to promote healing.Type: ApplicationFiled: June 23, 2011Publication date: December 27, 2012Inventor: Richard A. Cloonan
-
Patent number: 8337870Abstract: An active agent delivery composition is provided that allows topical delivery of active agents including vitamin A and its derivatives. A polyhalogenic vehicle such as methoxyonafluorobutane or ethoxyonafluorobutane serves as a coupler for an active agent and a silicone carrier so as to allow solubilization of active agents not normally miscible in silicones and providing a moisture maintaining composition.Type: GrantFiled: February 24, 2010Date of Patent: December 25, 2012Assignee: Young Pharmaceuticals, Inc.Inventor: John E. Kulesza
-
Patent number: 8318816Abstract: Compositions and methods for transport or release of therapeutic and diagnostic agents or metabolites or other analytes from cells, compartments within cells, or through cell layers or barriers are described. The compositions include a membrane barrier transport enhancing agent and are usually administered in combination with an enhancer and/or exposure to stimuli to effect disruption or altered permeability, transport or release. In a preferred embodiment, the compositions include compounds which disrupt endosomal membranes in response to the low pH in the endosomes but which are relatively inactive toward cell membranes (at physiologic pH, but can become active toward cell membranes if the environment is acidified below ca. pH 6.8), coupled directly or indirectly to a therapeutic or diagnostic agent. Other disruptive agents can also be used, responsive to stimuli and/or enhancers other than pH, such as light, electrical stimuli, electromagnetic stimuli, ultrasound, temperature, or combinations thereof.Type: GrantFiled: April 30, 2010Date of Patent: November 27, 2012Assignee: University of WashingtonInventors: Allan S. Hoffman, Patrick S. Stayton, Niren Murthy
-
Publication number: 20120282207Abstract: The present invention provides novel antimicrobial compositions. In one embodiment, the antimicrobial composition comprises an antimicrobial effective amount of a mixture comprising (a) two or more fatty acids, each of which is natural or naturally derived, and (b) at least one of (i) a natural or naturally derived product, (ii) an alcoholic solvent, or (iii) an organic acid or a salt thereof. The present invention also provides a product comprising a preservative effective amount of the aforementioned mixture.Type: ApplicationFiled: May 3, 2012Publication date: November 8, 2012Applicant: Lincoln Manufacturing Inc.Inventor: Patrick Jay Lutz
-
Publication number: 20120282172Abstract: The present invention provides a system presenting site-specific accumulation through a ligand that specifically targets a receptor overexpressed on the surface of specific cells within a target organ, like, for example, tumor cells and/or vascular cells of tumor blood vessels. Moreover, this invention provides a method where, upon internalization of the previous-mentioned system by the target cells, triggered release at a high rate of the associated agent takes place, permitting efficient intracellular delivery and, thus, increased concentration of the transported cargo at the target site. Overall, this invention provides a method for the diagnosis, prevention and treatment of human diseases and disorders.Type: ApplicationFiled: May 9, 2012Publication date: November 8, 2012Applicants: Centro de Neurociencias e Biologia Celular, Universidade de CoimbraInventors: João Nuno Sereno de Almeida Moreira, Vera Lúcia Dantas Nunes Caldeira de Moura, Sérgio Paulo de Magalhães Simões, Maria da Conceição Monteiro Pedroso de Lima
-
Patent number: 8302774Abstract: Compositions and methods are disclosed for stabilizing glycerin-in-oil emulsions, which can be used to significantly reduce thermal instability or instability over time compared to traditional cosmetics or topical formulations. The compositions comprise one or more oil-soluble rheological modifiers and optionally one or more emulsifiers in a glycerin-in-oil emulsion.Type: GrantFiled: December 15, 2010Date of Patent: November 6, 2012Assignee: Avon Products, Inc.Inventors: David Alan Binder, Bing C. Mei, Thi N. Do, George Willms, Hossein A. Baghdadi
-
Patent number: 8288353Abstract: A method for restructuring the epidermis with a composition, wherein said composition includes a polyol-glycoside and said polyol-glycoside is obtained by the acetalization of a polyol with a reducing sugar.Type: GrantFiled: February 22, 2011Date of Patent: October 16, 2012Assignee: Societe d'Exploitation de Produits pour les Industries Chimiques SEPPICInventors: Corinne Stoltz, Christine Garcia, Jean-Pierre Boiteux, Herve Rolland, Guy Tabacchi, Alain Milius
-
Patent number: 8273378Abstract: Dialysis solutions comprising pyrophosphates and methods of making and using the dialysis solutions are provided. In an embodiment, the present disclosure provides a dialysis solution comprising a stable and therapeutically effective amount of pyrophosphate. The dialysis solution can be sterilized, for example, using a technique such as autoclave, steam, high pressure, ultra-violet, filtration or combination thereof. The dialysis solution can be in the form of a concentrate.Type: GrantFiled: January 14, 2010Date of Patent: September 25, 2012Assignees: Baxter International, Inc., Baxter Healthcare S.A.Inventors: Bruce L. Riser, Paul Zieske, Sujatha Karoor, Himanshu D. Patel